Form: 8-K

Current report filing

December 23, 1997

8-K: Current report filing

Published on December 23, 1997



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


--------------


FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934


Date of report (Date of earliest event reported) December 22, 1997
----------------------------

COMMONWEALTH BIOTECHNOLOGIES, INC.
----------------------------------
(Exact Name of Registrant as Specified in Charter)



Virginia 001-13467 56-1641133
-------- --------- ----------
(State or Other Jurisdiction of (Commission File Number) (IRS Employer Identification No.)
Incorporation)


911 East Leigh Street, Suite G-19, Richmond, Virginia 23219
-------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number, including area code: (804) 648-3820
------------------


N/A
-------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)







Item 5. Other Events.

On December 22, 1997, the Registrant announced that it plans to develop
a new 30,000 square foot facility in Chesterfield County, Virginia. The new
facility will be used by the Registrant to more effectively serve its existing
client base and expand the Registrant's capabilities to support growth. A copy
of the press release relating to the announcement is attached as an exhibit
hereto.

The Registrant is currently considering various financing
opportunities, including tax-exempt municipal financing, to complete the
development project.

Item 7. Financial Statements and Exhibits.

(a) Financial Statements of Businesses Acquired.

Not applicable.

(b) Pro Forma Financial Information.

Not applicable.

(c) Exhibits.

99.1 Press Release, dated December 22, 1997, announcing plans
to develop 30,000 square foot facility







SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


COMMONWEALTH BIOTECHNOLOGIES, INC.



By: /s/ Robert B. Harris, Ph.D.
---------------------------
Robert B. Harris, Ph.D.
President







December 23, 1997







EXHIBIT INDEX


Number Description of Exhibit
- ------ ----------------------

99.1 Press Release, dated December 22, 1997, announcing plans to
develop 30,000 square foot facility.